These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 39062659)

  • 1. Ubiquitination-Related Gene Signature, Nomogram and Immune Features for Prognostic Prediction in Patients with Head and Neck Squamous Cell Carcinoma.
    Yang H; Zhou L; Shi M; Yu J; Xie Y; Sun Y
    Genes (Basel); 2024 Jul; 15(7):. PubMed ID: 39062659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seven Immune-Related Genes' Prognostic Value and Correlation with Treatment Outcome in Head and Neck Squamous Cell Carcinoma.
    Mu R; Shen Y; Guo C; Zhang X; Yang H; Yang H
    Mediators Inflamm; 2023; 2023():8533476. PubMed ID: 39282247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H
    Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification novel prognostic signatures for Head and Neck Squamous Cell Carcinoma based on ceRNA network construction and immune infiltration analysis.
    Zhou H; He Y; Li L; Wu C; Hu G
    Int J Med Sci; 2021; 18(5):1297-1311. PubMed ID: 33526991
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel comprehensive immune-related gene signature as a promising survival predictor for the patients with head and neck squamous cell carcinoma.
    Fang R; Iqbal M; Chen L; Liao J; Luo J; Wei F; Wen W; Sun W
    Aging (Albany NY); 2021 Apr; 13(8):11507-11527. PubMed ID: 33867351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of SASP-Related Gene Signature of Radiation Therapy in Head and Neck Squamous Cell Carcinoma.
    Lee MK; Woo SR; Noh JK; Min S; Kong M; Lee YC; Ko SG; Eun YG
    Mol Cancer Ther; 2024 Sep; 23(9):1348-1359. PubMed ID: 38959066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Chromatin Regulator-related Molecular Subtypes and a Signature to Predict Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma.
    Huang J; Xu Z; Wang Z; Zhou C; Shen Y
    Curr Cancer Drug Targets; 2024; 24(8):804-819. PubMed ID: 38310463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
    Zhang F; Liu Y; Yang Y; Yang K
    BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma.
    Li C; Wu ZH; Yuan K
    Dis Markers; 2020; 2020():8899337. PubMed ID: 33133307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Signature of N
    Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
    Front Immunol; 2022; 13():809872. PubMed ID: 35185897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma.
    Mao R; Chen Y; Xiong L; Liu Y; Zhang T
    Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
    Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
    Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
    Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
    BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas.
    Ma B; Li H; Qiao J; Meng T; Yu R
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33111959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma.
    Yang C; Mei H; Peng L; Jiang F; Xie B; Li J
    Comput Math Methods Med; 2020; 2020():7397132. PubMed ID: 33456497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
    Song D; Tian J; Han X; Li X
    Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of macrophages in head and neck squamous cell carcinoma and development of MRG-based risk signature.
    Liu L; Liu Q
    Sci Rep; 2024 Apr; 14(1):9914. PubMed ID: 38688945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma.
    Chen L; Cai Z; Lyu K; Cai Z; Lei W
    Bioengineered; 2021 Dec; 12(1):2311-2325. PubMed ID: 34167440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.